| [1] |
International Diabetes Federation, IDF Diabetes Atlas: seveth edition [C]. International Diabetes Federation, 2015.
|
| [2] |
Gerstein H C, Miller M E, Byington R P. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes[J]. Kardiologia Polska, 2008, 66 (9):1013-1019.
|
| [3] |
Stratton I M, Adler A I, Neil H A, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study[J]. Bmj Clinical Research, 2000, 321(7258):405-412.
|
| [4] |
Turner R C, Cull C A, Frighi V, et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group[J]. Jama, 1999, 281(21):2005.
|
| [5] |
Williamson D F, Faulconbridge L F, Wadden T A, et al. Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes— NEJM[J]. New England Journal of Medicine, 2013, 369(24):2356.
|
| [6] |
Rubino F, Kaplan L M, Schauer P R, et al. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus[J]. Annals of Surgery, 2010, 251(3):399-405.
|
| [7] |
Rubino F, Nathan D M, Eckel R H, et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: a Joint Statement by International Diabetes Organizations[J]. Diabetes Care, 2016, 12(6):1144.
|
| [8] |
中国医师协会外科医师分会肥胖和糖尿病外科医师委员会. 中国肥胖和2型糖尿病外科治疗指南（2014）[J]. 中国实用外科杂志, 2014, 8(11):499-504.
|
| [9] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2013年版)[J]. 中华内分泌代谢杂志, 2014, 30(10):26-89.
|
| [10] |
Yau J W Y, Rogers S L, Kawasaki R, et al. Global Prevalence and Major Risk Factors of Diabetic Retinopathy[J]. Diabetes Care, 2012, 35(3):556-564.
|
| [11] |
Lancet. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group[J]. Lancet, 1998, 352(9131):837.
|
| [12] |
Group A S, Group A E S, Chew E Y, et al. Effects of medical therapies on retinopathy progression in type 2 diabetes[J]. New England Journal of Medicine, 2012, 367(25):37.
|
| [13] |
Varadhan L, Humphreys T, Hariman C, et al. GLP-1 agonist treatment: implications for diabetic retinopathy screening[J]. Diabetes Research & Clinical Practice, 2011, 94(3):e68-71.
|
| [14] |
Miras A D, Chuah L L, Lascaratos G, et al. Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes[J]. Diabetes Care, 2012, 35(12):e81.
|
| [15] |
Thomas R L, Prior S L, Barry J D, et al. Does bariatric surgery adversely impact on diabetic retinopathy in persons with morbid obesity and type 2 diabetes? A pilot study[J]. Journal of Diabetes & Its Complications, 2014, 28(2):191-195.
|
| [16] |
Murphy R, Jiang Y, Booth M, et al. Progression of diabetic retinopathy after bariatric surgery[J]. Diabetic Medicine A Journal of the British Diabetic Association, 2015, 32(9):1212-1220.
|
| [17] |
Banks J, Adams S T, Laughlan K, et al. Roux-en-Y gastric bypass could slow progression of retinopathy in type 2 diabetes: a pilot study[J]. Obesity Surgery, 2015, 25(5):777.
|
| [18] |
Singh R P, Gans R, Kashyap S R, et al. Effect of bariatric surgery versus intensive medical management on diabetic ophthalmic outcomes[J]. Diabetes Care, 2015, 38(3):e32-33.
|
| [19] |
Miras A D, Chuah L L, Khalil N, et al. Type 2 diabetes mellitus and microvascular complications 1 year after Roux-en-Y gastric bypass: a case-control study[J]. Diabetologia, 2015, 58(7):1443-1447.
|
| [20] |
Amin A M, Wharton H, Clarke M, et al. The impact of bariatric surgery on retinopathy in patients with type 2 diabetes: a retrospective cohort study[J]. Surgery for Obesity & Related Diseases, 2015, 12(3):606.
|
| [21] |
Postma M J, De Z D. The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus[J]. Nephrology Dialysis Transplantation, 2009, 24(10):2975-2983.
|
| [22] |
Ikramuddin S, Korner J, Lee W J, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial[J]. Jama, 2013, 309(21):2240.
|
| [23] |
Agrawal V, Khan I, Rai B, et al. The effect of weight loss after bariatric surgery on albuminuria[J]. Clin Nephrol. 2008, 70(3):194-202.
|
| [24] |
Heneghan H M, Cetin D, Navaneethan S D, et al. Effects of Bariatric Surgery on Diabetic Nephropathy After 5 Years of Follow-Up[J]. Surgery for Obesity & Related Diseases Official Journal of the American Society for Bariatric Surgery, 2013, 9(1):7-14.
|
| [25] |
Brethauer S A, Aminian A, Romerotalamás H, et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus[J]. Annals of Surgery, 2013, 258(4):628.
|
| [26] |
Schauer P R, Bhatt D L, Kirwan J P, et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes—3-Year Outcomes—NEJM[J]. New England Journal of Medicine, 2014, 371(371):680-681.
|
| [27] |
Upala S, Wijarnpreecha K, Congrete S, et al. Bariatric surgery reduces urinary albumin excretion in diabetic nephropathy: a systematic review and meta-analysis[J]. Surgery for Obesity & Related Diseases, 2016, 12(5):1037-1044.
|
| [28] |
蔡洁，董继宏，汪昕. 糖尿病性周围神经病常用评分量表比较与研究[J]. 中华临床医师杂志:电子版, 2009, 3(1):12-17.
|
| [29] |
Hartland A J, Khan A, Mirza S, et al. Diabetic peripheral neuropathy presenting after bariatric surgery-enduced resolution of type 2 diabetes[J]. Obesity Facts, 2013, 6:106.
|
| [30] |
Müllerstich B P, Fischer L, Kenngott H G, et al. Gastric bypass leads to improvement of diabetic neuropathy independent of glucose normalization:results of a prospective cohort study (DiaSurg 1 study)[J]. Annals of Surgery, 2013, 258(5):760.
|
| [31] |
Adams T D, Gress R E, Smith S C, et al. Long-term mortality after gastric bypass surgery[J]. New England Journal of Medicine, 2007, 357(8):753.
|
| [32] |
Heneghan H M, Meron-Eldar S, Brethauer S A, et al. Effect of Bariatric Surgery on Cardiovascular Risk Profile[J]. American Journal of Cardiology, 2011, 108(10):1499-1507.
|
| [33] |
Sjöström L, Peltonen M, Jacobson P, et al. Bariatric Surgery and Long-term Cardiovascular Events[J]. Jama, 2012, 307(1):56.
|
| [34] |
Romeo S, Maglio C, Burza M A, et al. Cardiovascular Events After Bariatric Surgery in Obese Subjects With Type 2 Diabetes[J]. Diabetes Care, 2012, 35(12):2613.
|
| [35] |
Mingrone G, Panunzi S, De G A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial[J]. Obésité, 2016, 386(1):964-973.
|